key: cord-0968794-p6jq3a4n authors: Ahmad, Adeel; Islam, Zara; Manzoor Ahmad, Saad; Sarfraz, Zouina; Sarfraz, Azza; Felix, Miguel; Cherrez‐Ojeda, Ivan title: The correlation of D‐dimer to stroke diagnosis within 24 hours: A meta‐analysis date: 2022-02-04 journal: J Clin Lab Anal DOI: 10.1002/jcla.24271 sha: d4f53df2d2c2aa37a375e994ce13cd465cd97c99 doc_id: 968794 cord_uid: p6jq3a4n BACKGROUND: Diagnosing D‐Dimer early is essential to optimize clinical treatment and quality of life and reduce mortality. This study aims to identify the difference of D‐Dimer levels (ng/ml) in patients with stroke within the 6‐ and 24‐h period compared to patients that mimic stroke. METHODS: An electronic database search across PubMed/MEDLINE, Cochrane, Web of Science, CINAHL, EMBASE, and Scopus was conducted until December 10, 2021. Studies were eligible if they included adult patients with stroke compared to stroke mimics or controls reporting D‐Dimer values. Quality assessment was conducted using GRADE. The standardized mean difference and 95% confidence intervals were calculated in addition to the difference of means in the crude form. Heterogeneity was assessed using Cochran's Q statistic and the I (2) index. A random‐effects model was used. The statistical analysis was conducted using RevMan 5.4. RESULTS: Out of 2901, there were 318 (11%) participants from upper‐middle‐income countries, whereas the others were from high‐income countries. Large positive effect size was found for D‐Dimer in the stroke group (Cohen's d = 2.82 [1.73–3.9]; p < 0.00001), meaning that those with stroke had higher D‐Dimer values on presentation compared to the stroke mimics/controls. A large difference in means was found in the two groups (MD = 685.1 [324.2, 1045.99]; p < 0.00001), suggesting that there was a significantly higher laboratory value in the stroke group. CONCLUSION: Our findings must be used in caution as the most reliable diagnostic tests for stroke are CT and MRI. Laboratory testing such as D‐Dimer values is a valuable clinical adjuvant in diagnosing total stroke. In 1970, the World Health Organization (WHO) defined stroke as "rapidly developing clinical signs of global or focal disturbance in the cerebral function that lasting more than 24 h or leading to death with no notable cause other than of vascular origin". 1 While this definition is used across the world, the WHO definition relies heavily on clinical symptoms. It is currently considered outdated by the American Stroke Association and the American Heart Association due to advances in the nature, timing, and clinical recognition of stroke and its mimics, in addition to the progressing imaging findings that require an updated definition. 2, 3 The global prevalence of stroke in 2019 was reported at 101.5 million individuals, whereas ischemic stroke was reported in 77.2 million people. 4 Overall, the age-standardized stroke prevalence was highest in Southeast Asia, the Middle East, East Asia, and Oceania. 4 In 2019, 6.6 million deaths occurred due to cerebrovascular disease worldwide. 4 Further, ischemic stroke rose from 13th to 8th leading cause of global YLL (years of life lost because of premature mortality) between 1990 and 2019. 4 Hemostasis is the property of circulation where blood retains fluidity within the vasculature, whereas the system simultaneously prevents excessive blood loss upon injury. 5 When the vascular injury occurs, clotting reactions are initiated, creating an insoluble fibrin-platelet plug at the site of the vessel wall defect, arresting blood loss, and finally restoring the vascular integrity. 6 The activation releases many substances required in platelet aggregation and initiates the coagulation cascade, leading to the formation of cross-linked fibrin, creating a clot at the injury site. During the fibrinolysis process, plasmin cleaves fibrinogen and soluble fibrin. The smallest oligomer is D-dimer. 7 On laboratory testing, the D-Dimer levels reflect the intravascular levels of fibrin turnover, confirming the plasmin and thrombin generation that has occurred. 6 When considering clinical practice, abnormal elevation of D-Dimer indicates disseminated intravascular clotting, whereas low levels aid in ruling out thromboembolic events such as pulmonary embolism and deep venous thrombosis. 8, 9 While D-Dimer levels have been known to be associated with long-term mortality in the population, few studies assess the D-Dimer levels and stroke incidence. 10 This study aims to identify the D-Dimer levels (ng/ml) in patients with stroke within the 6-and 24-h period compared to patients that mimic stroke. In this area, we conduct a meta-analysis to systematically analyze the correlation between D-dimer levels and stroke incidence. In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA Statement 2020), clinical trials, observational studies, and case-controlled studies (five or more patients) with a stroke group and a stroke mimic/control group that reported D-Dimer values within the 24-h period were included. The following study types were included: Controlled/randomized clinical trials, retrospective or prospective cohorts, case-controlled studies with five or more patients. The studies employed adult patients aged 18 or above with no gender predilections. Studies that reported laboratory values of patients with stroke compared to stroke mimics/controls were included. All other studies were excluded. We used a systematic search strategy to assess electronic databases as per the PRISMA checklist ( Figure 1 ). The PRISMA checklist and protocol are attached in Appendices S1 and S2. The search was conducted from inception until December 10, 2021. There were no language restrictions meaning that non-English studies were translated to English. PubMed/MEDLINE, Cochrane, Web of Science, CINAHL, EMBASE, and Scopus were searched. We manually searched SAGE, Elsevier, Science Direct, and Google Scholar to ensure no studies were missing. The reference lists of all screened were also searched (umbrella methodology). The search terms across the databases comprised the following using the BOOLEAN (and/or) logic: D-Dimer, Laboratory, Stroke, Ischemic, Hemorrhagic, Trial, and Cohort. The titles and abstracts of the screened studies were reviewed and screened independently by all reviewers. Any disagreements were resolved by active discussion. Cohen's coefficient of the agreement was computed to quantify the inter-reviewer agreement. The studies were stored in a bibliography management software named Endnote X9 (Clarivate Analytics). The deduplication feature was applied using the software when screening the studies. We sought to meta-analyze the means and standard deviations of D-Dimer, applying a random-effects model. These variables were continuous, and the difference in means using 95% confidence intervals was computed. Moreover, the standardized mean difference that was reported as Cohen's d with the 95% confidence interval was plotted and reported in the results. A funnel plot was utilized to test for publication bias, where we ascertained the heterogeneity between the included studies. The heterogeneity between the included studies was tested using the χ 2 -based Q test and the I 2 index. The overall Kappa score calculated for the inter-reviewer agreement was 0.92. In total, 3315 studies were identified from databases, Table 1 . Large heterogeneity was found in the included studies, owing to the different nature under which they were conducted. A funnel plot was created to visually inspect publication bias, as depicted in Figure 6 . We found three studies deviating from an inverted funnel shape, with the other six being within a reasonable bound ( Figure 6 ). No. Table 2 . The GRADE approach was used to assess the quality of D-Dimer evidence for stroke detection across the 11 studies. Overall, eight studies had moderate GRADE certainty ratings, with two being high and one low. The evidence presented in this meta-analysis is of moderate quality. Hence, our findings must be used with caution and informed clinical application. While several observational studies report associations between D-Dimer levels and the incidence of stroke, the findings have been inconsistent so far. [23] [24] [25] Yuan and colleagues analyzed the associations between D-Dimer and the risk of stroke (i.e., pre-stroke) employing a sample set of 22,590 patients. 22 The authors found that the D-Dimer levels increased the risk of total stroke by 40% (RR = The annual number of deaths due to strokes increased substantially from 1990 to 2019, despite the reductions in age-standardized rates, specifically in the 70 and above age group. The highest number of age-standardized stroke-related mortality and DALY rates belonged to the low-income countries as per the World Bank classification. 31 We posit that without the implementation of primary prevention strategies and cheap "filtering" tests available at primary care centers, the stroke burden will continue to rise across the world, particularly in low-and middle-income countries. In our meta-analysis, only two upper-middle-income countries were represented, whereas the other nine were HIC (Figure 7 ). The findings from this meta-analytical study can help guide evidence- There are certain limitations in this meta-analysis. First, we could not differentiate results based on the different stroke types because of the paucity of data. Second, the number of included studies was limited due to the lack of reported data from LMIC. Third, we could not account for confounding factors as the study populations were not demarcated in the included studies. Finally, racial data were not aligned to the clinical outcomes; hence, a racial-specific metaanalysis could not be undertaken. Based on our study discoveries, high D-Dimer levels are strongly correlated to a stroke diagnosis. There is no evidence for the different stroke types, and our clinical applications are limited to total stroke incidences. The quantification of D-Dimer levels across the different stroke subtypes and TIA must be substantiated to corroborate our findings. Author, year GRADE certainty ratings Cerebrovascular disease in the community: results of a WHO collaborative study An updated definition of stroke for the 21st century: a statement for healthcare professionals from the The definition of stroke Heart disease and stroke statistics-2021 update: a report from the A cell-based model of hemostasis Is D-dimer helpful in evaluating stroke patients? A systematic review Fibrin D-dimer: a useful clinical marker of thrombogenesis? Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study Venous Thromboembolism, Corticosteroids and COVID-19: A Systematic Review and Meta-Analysis Seminars in Vascular Medicine. Copyright© 2005 by Blood biomarkers for the early diagnosis of stroke: the stroke-chip study A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke Value of biomarkerbased diagnostic test in differential diagnosis of hemorrhagicischemic stroke Discriminative capacity of biomarkers for acute stroke in the emergency department Plasma biomarkers in the diagnosis of acute ischemic stroke Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes Hemostatic disturbances in acute ischemic stroke: a study of 86 patients Activation of coagulation in acute cardioembolic stroke Relationships between Ddimer levels and stroke risk as well as adverse clinical outcomes after acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis Elevated levels of D-dimers increase the risk of ischaemic and haemorrhagic stroke Plasma d-dimer and incident ischemic stroke and coronary heart disease: the atherosclerosis risk in communities study Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men Medical Procedure & Facility Cost, Procedure Information for Patients Get lowest D dimer test cost at $239|normal range, and more Stroke care in Pakistan Total Population -South Asia The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author) and declared no conflicts of interest. All data used and acquired for this study are available online.